XML 111 R53.htm IDEA: XBRL DOCUMENT v3.3.1.900
Segment Information (Tables)
 12 Months Ended
Dec. 31, 2015
Segment Reporting [Abstract]  
Revenue by product
 
For the Years Ended December 31,
 
2015
 
2014
 
2013
(In millions)
United
States
 
Rest of
World
 
Total
 
United
States
 
Rest of
World
 
Total
 
United
States
 
Rest of
World
 
Total
Multiple Sclerosis (MS):
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
TECFIDERA
$
2,908.2

 
$
730.2

 
$
3,638.4

 
$
2,426.6

 
$
482.6

 
$
2,909.2

 
$
864.4

 
$
11.7

 
$
876.1

AVONEX
1,790.2

 
840.0

 
2,630.2

 
1,956.7

 
1,056.4

 
3,013.1

 
1,902.4

 
1,103.1

 
3,005.5

PLEGRIDY
227.1

 
111.4

 
338.5

 
27.8

 
16.7

 
44.5

 
—

 
—

 
—

TYSABRI
1,103.1

 
783.0

 
1,886.1

 
1,025.1

 
934.4

 
1,959.5

 
814.2

 
712.3

 
1,526.5

FAMPYRA
—

 
89.7

 
89.7

 
—

 
80.2

 
80.2

 
—

 
74.0

 
74.0

Hemophilia:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
ELOCTATE
308.3

 
11.4

 
319.7

 
58.4

 
—

 
58.4

 
—

 
—

 
—

ALPROLIX
208.9

 
25.6

 
234.5

 
72.1

 
3.9

 
76.0

 
—

 
—

 
—

Other product revenues:
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
FUMADERM
—

 
51.4

 
51.4

 
—

 
62.5

 
62.5

 
—

 
60.2

 
60.2

Total product revenues
$
6,545.8

 
$
2,642.7

 
$
9,188.5

 
$
5,566.7

 
$
2,636.7

 
$
8,203.4

 
$
3,581.0

 
$
1,961.3

 
$
5,542.3
Geographic information
December 31, 2015 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
6,545.8

 
$
1,497.6

 
$
668.1

 
$
143.7

 
$
333.3

 
$
9,188.5

Unconsolidated joint business revenues
$
1,269.8

 
$
3.5

 
$
—

 
$
—

 
$
65.9

 
$
1,339.2

Other revenues from external customers
$
142.0

 
$
29.6

 
$
1.6

 
$
62.9

 
$
—

 
$
236.1

Long-lived assets
$
1,296.5

 
$
879.4

 
$
2.3

 
$
7.7

 
$
1.7

 
$
2,187.6

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2014 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
5,566.7

 
$
1,383.9

 
$
811.8

 
$
112.8

 
$
328.2

 
$
8,203.4

Unconsolidated joint business revenues
$
1,117.1

 
$
7.7

 
$
—

 
$
—

 
$
70.6

 
$
1,195.4

Other revenues from external customers
$
212.6

 
$
31.6

 
$
1.8

 
$
58.5

 
$
—

 
$
304.5

Long-lived assets
$
1,055.5

 
$
701.9

 
$
2.5

 
$
2.6

 
$
3.2

 
$
1,765.7

 
 
 
 
 
 
 
 
 
 
 
 
December 31, 2013 (In millions)
U.S.
 
Europe(1)
 
Germany
 
Asia
 
Other
 
Total
Product revenues from external customers
$
3,581.0

 
$
1,170.2

 
$
417.7

 
$
93.2

 
$
280.2

 
$
5,542.3

Unconsolidated joint business revenues
$
1,087.3

 
$
1.6

 
$
—

 
$
3.2

 
$
33.9

 
$
1,126.0

Other revenues from external customers
$
193.5

 
$
26.1

 
$
1.2

 
$
43.1

 
$
—

 
$
263.9

Long-lived assets
$
984.4

 
$
758.3

 
$
2.5

 
$
2.1

 
$
3.3

 
$
1,750.7